Chemical Structure (Zarontin 01)
Zarontin Solution
Product Images NDC 0071-2418
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Zarontin (NDC 0071-2418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Parke-davis Div Of Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Company Logo (Zarontin 02)
Sefizer is a product that is distributed by Parke-Davis, which is a division of Pfizer Inc. The company is located in New York, NY 10017.*
Logo (Zarontin 02a)
Sefizer is a product or brand name that is distributed by Parke-Davis, which is a division of Pfizer Inc. located in New York, NY 10017.*
Principal Display Panel (474 mL Bottle Label)
This is a medication guide for Zarontin® oral solution, containing 250mg per 5 liters of Ethosuximide in a raspberry flavored base. It is recommended to always dispense medication with the accompanying medication guide. The solution should be stored at 20°-25°C (66°-77°F) in tight containers and protected from freezing and light. The dispensing container must be child-resistant and light-resistant as defined in the USP. For dosage and use, please refer to the accompanying prescribing information. This medication is distributed by Parke-Davis Division of Pize Inc, NY, NY 10017. No other details are available from the given text.*
Principal Display Panel (474 mL Bottle Carton)
This is a description of a medication called Zarontin® which is distributed by Parke-Davies. It contains the active ingredient Ethosuximide and is available in oral solution form. Each 5 mL of oral solution contains 250 mg of Ethosuximide. The medication is dispensed in a tight and resistant container and has a rispberry flavor. There are contact details for Parke-Davies included, and the medication is available in divisons of 1 Pint (474 L).*
Principal Display Panel (474 mL Bottle Label)
Zarontin is an oral solution medication containing Ethosuximide. Each 5mL of this raspberry-flavored base medication contains 250mg of ethosuximide. The medication guide should always be dispensed with this medication. The medication should be stored at a temperature ranging from 20°C-25°C (68°F-77°F), in tightly sealed, light-resistant and child-resistant containers. The medication should be protected from freezing and light. Please see the accompanying prescribing information for the dosage and usage directions. This medication is distributed by Parke-Davis, a division of Pfizer Inc in NY, NY.*
Principal Display Panel (474 mL Bottle Carton)
This is a description for a medication called Zarontin® (Ethosuximide) in the form of an oral solution, distributed by Parke-Davis Division of Pfizer Inc in New York. The solution comes in raspberry flavor and each 5 mL of oral solution contains 250 mg ethosuximide. The prescription information should be consulted for dosage and use instructions. The medication should be dispensed and stored in tight and light-resistant child-resistant containers.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
